Halavonich Lauren, Robert Sophie, McGraw Dan, Weeda Erin, Mullinax Kristen, Bass Bailey
Ment Health Clin. 2020 Jan 9;10(1):25-29. doi: 10.9740/mhc.2020.01.025. eCollection 2020 Jan.
Delirium is an acute, fluctuating change in mental status, often associated with behavioral manifestations such as agitation. Literature suggests that many patients who continue on antipsychotics for extended management of delirium are not provided instructions for discontinuation. However, there is a positive correlation between consult services and instructions for discontinuation. The objective of this study was to determine the frequency at which patients with delirium were prescribed an antipsychotic at hospital discharge and to characterize discharge antipsychotic prescribing for psychiatric consult and nonconsult cohorts.
This study was a retrospective chart review of adult patients with an International Classification of Diseases 10th revision code of delirium who received at least 1 dose of antipsychotic during their admission. Inclusion criteria were all patients aged 18 years or older with a diagnosis of or relating to delirium who were administered antipsychotics during their admission.
A total of 152 patients were included, of which 43 received a psychiatric consult. Antipsychotics were prescribed at discharge for management of delirium for 52 (34.2%) of 152 total patients. More patients in the psychiatric consult cohort were discharged with an antipsychotic as compared to those in the nonconsult cohort (53.3% vs 26.6%, = .02).
Compared to previous studies, patients in this retrospective review were more likely to be discharged on an antipsychotic that was initiated during admission for management of delirium. Findings from this study also align with prior research demonstrating a positive association between antipsychotic discharge instructions and specialty consult recommendations.
谵妄是一种急性、波动的精神状态改变,常伴有激越等行为表现。文献表明,许多因谵妄长期使用抗精神病药物治疗的患者未得到停药指导。然而,会诊服务与停药指导之间存在正相关。本研究的目的是确定谵妄患者出院时开具抗精神病药物的频率,并描述精神科会诊组和非会诊组出院时抗精神病药物的处方情况。
本研究是一项回顾性病历审查,纳入国际疾病分类第十版编码为谵妄的成年患者,这些患者在住院期间至少接受了1剂抗精神病药物治疗。纳入标准为所有18岁及以上、诊断为谵妄或与谵妄相关且在住院期间接受抗精神病药物治疗的患者。
共纳入152例患者,其中43例接受了精神科会诊。152例患者中,有52例(34.2%)出院时开具了用于治疗谵妄的抗精神病药物。与非会诊组相比,精神科会诊组出院时开具抗精神病药物的患者更多(53.3%对26.6%,P = 0.02)。
与先前的研究相比,在这项回顾性研究中,患者出院时更有可能继续使用住院期间开始用于治疗谵妄的抗精神病药物。本研究的结果也与先前的研究一致,表明抗精神病药物出院指导与专科会诊建议之间存在正相关。